Preoperative predictors of poorer outcomes from hip arthroscopic labral preservation, capsular plication, and cam osteoplasty in the setting of BDDH are age ≥42 years old, broken Shenton line, osteoarthritis, Tönnis angle ≥15°, and VCA angle ≤17° on preoperative radiographs. Intraoperative predictors of poorer outcomes are severe acetabular chondral damage and even mild femoral chondral damage. Although the patients in the setting of BDDH may have good outcomes from isolated hip arthroscopy, caution is suggested for those with the aforementioned risk factors.

Patients with a broken Shenton line, FNS angle >140°, CE angle <19°, or BMI >23 kg/m(2) at the time of surgery are not good candidates for the arthroscopic management of DDH.

Purpose A frequent reason for revision surgery after total knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA) is periprosthetic joint infection (PJI). The efficacy of intrawound VP in preventing PJI after primary TKA or UKA is rarely reported. The purpose of this study was to investigate the efficacy and side effects of local high‐dose VP application to the joint to prevent PJI in TKA and UKA. Methods From 2010 to 2017, 166 consecutive patients that underwent primary TKA or UKA were enrolled. Seventy‐five patients (92 knees) did not receive VP (control group), while 90 patients (110 knees, VP group) received VP (intrawound, 1 g) before capsule closure during TKA and UKA. Aseptic wound complications, such as skin erosion, wound dehiscence, and prolonged wound healing, were evaluated within 3 months post‐operatively. PJI was assessed within a year post‐operatively. Results Seven patients (7.6%) in the control group and five patients (4.5%) in the VP group had PJI. No significant differences existed in the PJI rates between the groups. Aseptic operative wound complications occurred in 4 patients (4.3%) and 13 patients (11.8%), whereas prolonged operative wound healing occurred in 3 patients (3.3%) and 14 patients (12.7%) of patients in the control and VP group, respectively. Operative wound complications were significantly frequent in the VP group. Conclusions Intrawound VP administration does not decrease PJI occurrence in primary TKA and significantly causes aseptic wound complications. The use of intrawound VP for the prevention of PJI after primary TKA and UKA is not recommended. Level of evidence Level II.

No abstract

Background Several qualitative radiographic signs have been described to assess acetabular retroversion. However, quantitative assessment of acetabular version would be useful for more rigorous research purposes and perhaps to diagnose and treat hip disorders. Questions/purposes We developed a new quantitative index for acetabular version (p/a ratio). We determined the average p/a, compared it with previous radiographic signs for acetabular retroversion, and evaluated its relationship with anatomic acetabular version. Methods We calculated the p/a ratio by measuring p (distance from acetabular articular surface to posterior wall) and a (distance from acetabular articular surface to anterior wall) on plain hip AP radiographs and dividing p by a. P and a were assessed on the perpendicular bisector of the line between the teardrop and the lateral edge of the acetabulum. Using 185 hip radiographs from patients with suspected idiopathic osteonecrosis, we measured p/a and compared it with previous qualitative signs for acetabular retroversion. Using 62 hip CT images from patients with no osteoarthritis, we measured the anatomic anteversion at the height of the central femoral head and investigated its relationship with p/a. Results The average p/a was 2.05 in 185 hips, and most patients with a p/a greater than 2.05 had a negative qualitative retroversion sign. A correlation was observed between central anteversion and p/a (r = 0.84). Conclusions We believe this ratio can be considered a simple quantitative parameter to assess acetabular version using plain AP radiographs.